GPX4 and neoplasm: For example, Li et al. screened the molecular compound N6F11, which effectively triggered the degradation of GPX4, especially in tumor cells within the tumor microenvironment, but did not induce the degradation of GPX4 in immune cells, to successfully induce protective immunity [31].